Menu
Search
|

Menu

Close
X

Anika Therapeutics Inc ANIK.OQ (NASDAQ Stock Exchange Global Select Market)

34.23 USD
+0.11 (+0.32%)
As of Jul 20
chart
Previous Close 34.12
Open 34.13
Volume 66,676
3m Avg Volume 70,356
Today’s High 34.82
Today’s Low 34.10
52 Week High 68.57
52 Week Low 28.54
Shares Outstanding (mil) 14.66
Market Capitalization (mil) 872.76
Forward P/E 26.41
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.00 Mean rating from 4 analysts

KEY STATS

Revenue (mm, USD)
FY18
21
FY17
113
FY16
103
FY15
93
EPS (USD)
FY18
-0.455
FY17
1.959
FY16
2.154
FY15
2.006
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
26.41
32.76
Price to Sales (TTM)
vs sector
7.84
5.73
Price to Book (MRQ)
vs sector
3.57
5.47
Price to Cash Flow (TTM)
vs sector
23.12
23.29
Total Debt to Equity (MRQ)
vs sector
0.00
16.84
LT Debt to Equity (MRQ)
vs sector
0.00
12.51
Return on Investment (TTM)
vs sector
14.62
14.61
Return on Equity (TTM)
vs sector
15.11
16.34

EXECUTIVE LEADERSHIP

Joseph Darling
President, Chief Executive Officer, Director, Since 2018
Salary: --
Bonus: --
Sylvia Cheung
Chief Financial Officer, Treasurer, Secretary, Since 2013
Salary: $346,942.00
Bonus: $171,736.00
Edward Ahn
Chief Technology and Strategy Officer, Since 2014
Salary: $315,675.00
Bonus: $156,259.00
Richard Hague
Chief Commercial Officer, Since 2015
Salary: $315,000.00
Bonus: $127,575.00
Joseph Bower
Lead Independent Director, Since 2005
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Pharmaceuticals
Address:

32 Wiggins Ave
BEDFORD   MA   01730-2315

Phone: +1781.4579000

Anika Therapeutics, Inc. is an orthopedic medicines company. The Company is engaged in developing, manufacturing and commercializing products based on its hyaluronic acid (HA) technology. The Company's orthopedic medicine portfolio includes ORTHOVISC, MONOVISC, and CINGAL, which alleviate pain and restore joint function by replenishing depleted HA, and HYALOFAST, a solid HA-based scaffold to aid cartilage repair and regeneration. The Company's therapeutic offerings consist of products in the areas, including Orthobiologics, which includes viscosupplementation and regenerative orthopedic products; Dermal, which includes wound care products; Surgical, which includes products used to prevent post-surgical adhesions, and Other, which includes the Company's ophthalmic and veterinary products. The Company also offers products made from HA based on two other technologies: HYAFF, which is a solid form of HA, and ACP gel, an autocross-linked polymer of HA.

SPONSORED STORIES